![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00733213 |
A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.
Condition |
---|
Locally Advanced or Metastatic Prostate Cancer. |
Study Type: | Observational |
Study Design: | Case-Only, Retrospective |
Official Title: | Depiction of Prostate Cancer Treatment Alternatives in Greece |
Estimated Enrollment: | 310 |
Study Start Date: | January 2008 |
Study Completion Date: | March 2009 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Target Group: Patients diagnosed with Locally advanced or Metastatic Prostate Cancer
Inclusion Criteria:
Exclusion Criteria:
Greece | |
Research Site | |
Athens, Greece | |
Research Site | |
Karditsa, Greece | |
Research Site | |
Serres, Greece | |
Research Site | |
Xsanthi, Greece |
Study Director: | Panagiotis Pontikis, MD | AstraZeneca Greece |
Responsible Party: | AstraZeneca, SA Greece ( Dr Pontikis Panagiotis, MD Medical and Regulatory Affairs Director ) |
Study ID Numbers: | NIS-OGR-DUM-2007/1 |
Study First Received: | August 8, 2008 |
Last Updated: | March 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00733213 History of Changes |
Health Authority: | Greece: National Organization of Medicines |
Prostate Cancer, Treatment alternatives, Metastasis |
Prostatic Diseases Genital Neoplasms, Male Neoplasm Metastasis |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |